In-Hae Kim

2.4k total citations
25 papers, 2.2k citations indexed

About

In-Hae Kim is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine. According to data from OpenAlex, In-Hae Kim has authored 25 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Biochemistry, 19 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Pathology and Forensic Medicine. Recurrent topics in In-Hae Kim's work include Eicosanoids and Hypertension Pharmacology (22 papers), Hormonal Regulation and Hypertension (19 papers) and Alcohol Consumption and Health Effects (10 papers). In-Hae Kim is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (22 papers), Hormonal Regulation and Hypertension (19 papers) and Alcohol Consumption and Health Effects (10 papers). In-Hae Kim collaborates with scholars based in United States, Japan and Czechia. In-Hae Kim's co-authors include Bruce D. Hammock, Christophe Morisseau, John W. Newman, Kara Schmelzer, Lukáš Kubala, Jason P. Eiserich, Hsing-Ju Tsai, Takaho Watanabe, Kosuke Nishi and John D. Imig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

In-Hae Kim

25 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
In-Hae Kim United States	18	1.8k	1.1k	545	475	281	25	2.2k
Hsing-Ju Tsai United States	21	1.3k 0.7×	819 0.7×	418 0.8×	294 0.6×	186 0.7×	24	1.6k
Todd R. Harris United States	18	799 0.4×	369 0.3×	243 0.4×	161 0.3×	135 0.5×	28	1.1k
Horst Honeck Germany	18	583 0.3×	347 0.3×	173 0.3×	64 0.1×	262 0.9×	28	1.2k
Alison J. Draper United States	10	491 0.3×	310 0.3×	156 0.3×	92 0.2×	461 1.6×	10	996
Jessica F. Greene United States	10	501 0.3×	217 0.2×	159 0.3×	131 0.3×	136 0.5×	13	735
Mei‐Hui Hsu United States	24	435 0.2×	219 0.2×	81 0.1×	122 0.3×	679 2.4×	33	1.8k
P. Bentley Switzerland	28	615 0.3×	171 0.1×	148 0.3×	131 0.3×	838 3.0×	75	2.4k
Katrin Georgi Germany	11	478 0.3×	166 0.1×	178 0.3×	77 0.2×	115 0.4×	26	839
Aparajita Dey India	18	259 0.1×	279 0.2×	439 0.8×	26 0.1×	214 0.8×	34	1.3k
John Litchfield United States	19	124 0.1×	391 0.3×	138 0.3×	153 0.3×	328 1.2×	37	1.8k

Countries citing papers authored by In-Hae Kim

Since Specialization

Citations

This map shows the geographic impact of In-Hae Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In-Hae Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In-Hae Kim more than expected).

Fields of papers citing papers by In-Hae Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by In-Hae Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by In-Hae Kim. The network helps show where In-Hae Kim may publish in the future.

Co-authorship network of co-authors of In-Hae Kim

This figure shows the co-authorship network connecting the top 25 collaborators of In-Hae Kim. A scholar is included among the top collaborators of In-Hae Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with In-Hae Kim. In-Hae Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Jun‐Yan, Hsing-Ju Tsai, Christophe Morisseau, et al.. (2015). In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors. Biochemical Pharmacology. 98(4). 718–731. 16 indexed citations

Kim, In-Hae, et al.. (2015). Structure–activity relationships of amide–phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase. Bioorganic & Medicinal Chemistry. 23(22). 7199–7210. 16 indexed citations

Kim, In-Hae, In‐Hee Lee, Hisashi Nishiwaki, Bruce D. Hammock, & Kosuke Nishi. (2014). Structure–activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase. Bioorganic & Medicinal Chemistry. 22(3). 1163–1175. 13 indexed citations

Nishi, Kosuke, In-Hae Kim, Takaaki Itai, et al.. (2012). Immunochromatographic assay of cadmium levels in oysters. Talanta. 97. 262–266. 4 indexed citations

Kim, In-Hae, Kosuke Nishi, Christophe Morisseau, et al.. (2012). Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase. Bioorganic & Medicinal Chemistry Letters. 22(18). 5889–5892. 10 indexed citations

Scherman, Michaël, E. Jeffrey North, Victoria Jones, et al.. (2012). Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability. Bioorganic & Medicinal Chemistry. 20(10). 3255–3262. 69 indexed citations

Tsai, Hsing-Ju, Sung Hee Hwang, Christophe Morisseau, et al.. (2010). Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs. European Journal of Pharmaceutical Sciences. 40(3). 222–238. 68 indexed citations

Kim, In-Hae, et al.. (2009). Salicylate–urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities. Bioorganic & Medicinal Chemistry Letters. 19(6). 1784–1789. 21 indexed citations

Schmelzer, Kara, Hsing-Ju Tsai, In-Hae Kim, et al.. (2008). Inhibition of Soluble Epoxide Hydrolase Does Not Protect against Endotoxin-Mediated Hepatic Inflammation. Journal of Pharmacology and Experimental Therapeutics. 327(3). 707–715. 27 indexed citations

10.

Ulu, Arzu, Benjamin B. Davis, Hsing-Ju Tsai, et al.. (2008). Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model. Journal of Cardiovascular Pharmacology. 52(4). 314–323. 107 indexed citations

11.

Kim, In-Hae, et al.. (2007). 1,3-Disubstituted Ureas Functionalized with Ether Groups are Potent Inhibitors of the Soluble Epoxide Hydrolase with Improved Pharmacokinetic Properties. Journal of Medicinal Chemistry. 50(21). 5217–5226. 64 indexed citations

12.

Xu, Danyan, Ning Li, Yuxia He, et al.. (2006). Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proceedings of the National Academy of Sciences. 103(49). 18733–18738. 203 indexed citations

13.

Schmelzer, Kara, Bora İnceoğlu, Lukáš Kubala, et al.. (2006). Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proceedings of the National Academy of Sciences. 103(37). 13646–13651. 168 indexed citations

14.

Olearczyk, J, et al.. (2006). Substituted Adamantyl-Urea Inhibitors of the Soluble Epoxide Hydrolase Dilate Mesenteric Resistance Vessels. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1307–1314. 40 indexed citations

15.

Kim, In-Hae, Kosuke Nishi, Hsing-Ju Tsai, et al.. (2006). Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase. Bioorganic & Medicinal Chemistry. 15(1). 312–323. 49 indexed citations

16.

Nishi, Kosuke, Huazhang Huang, Shizuo G. Kamita, et al.. (2005). Characterization of pyrethroid hydrolysis by the human liver carboxylesterases hCE-1 and hCE-2. Archives of Biochemistry and Biophysics. 445(1). 115–123. 93 indexed citations

17.

Jung, Oliver, Ralf P. Brandes, In-Hae Kim, et al.. (2005). Soluble Epoxide Hydrolase Is a Main Effector of Angiotensin II–Induced Hypertension. Hypertension. 45(4). 759–765. 161 indexed citations

18.

Imig, John D., Xueying Zhao, J Olearczyk, et al.. (2005). An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension. Hypertension. 46(4). 975–981. 217 indexed citations

19.

Schmelzer, Kara, Lukáš Kubala, John W. Newman, et al.. (2005). Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proceedings of the National Academy of Sciences. 102(28). 9772–9777. 388 indexed citations

20.

Kim, In-Hae & Eiichi Kuwano. (2003). Synthesis and Structure-Activity Relationships of 6-Methyl-3-pyridyl Ethers as Anti-juvenile Hormone Agents. Journal of the Faculty of Agriculture Kyushu University. 47(2). 395–405. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact